Determination of antiphospholipid antibodies and Thrombophilia in women with recurrent miscarriage
DOI:
https://doi.org/10.52981/sjms.v8i2.889Keywords:
APA, ACA, ANA, Anti-dsDNA, RM, LA, APTT, PTAbstract
Background: Recurrent miscarriage is a critical problem in which many factors play a crucial role such as antiphospholipid antibodies (APA) and anticardiolipin antibodies (ACA). Recent studies pointed to a potential role of thrombophilias as a possible cause of recurrent miscarriage (RM).
Objectives: This study was conducted to determine the frequency of the primary and secondary antiphospholipid syndrome and the haemostatic abnormalities in women with history of RM.
Materials and Methods: This study was a case control study, conducted from Febraury-2008 to February -2011 in Khartoum State. A total of 100 women with three or more consecutive recurrent miscarriage without previous living babies as case group and 100 non complicated pregnant women were screened for the presence of antinuclear antibodies (ANA), anti-double stranded DNA (anti-dsDNA), antiphospholipid antibodies (APA IgM/IgG), and anticardiolipin antibodies (ACA/IgG) by using Enzyme Linked Immuno-Sorbent Assay (ELISA). Patients with history of three miscarriages with delivery of full-term or preterm babies in between or with medical termination of pregnancy were excluded from this study. Women positive for APA were asked for a repeat sample after 6 weeks to run confirmatory test. Patient and control groups were also screened for the count of platelets using Sysmex KXN-21, Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Thrombin Time (TT) using coagulometer Biobas 10.
Results: The frequencies for both APA and ACA were 20%. ANA and Anti-dsDNA were 12%. There was a significant correlation between age and the presence of APA (P=0.03), ACA (IgG) (P=0.04), ANA and Anti-dsDNA (P=0.013). Frequencies for, thrombocytopenia and lupus anticoagulant (LA) were 8% and 20% respectively. 5% had prolonged PT, whereas the remaining patient and control groups had normal results.
Conclusion: The data concluded that the frequencies of APA, ACA, ANA, Anti-dsDNA, in women with RM obtained in this study were in agreement to the frequencies for these parameters obtained in previous studies and their presence were significantly associated with recurrent miscarriage.
Recommendation: Frequencies of LA and thrombocytopenia were significantly associated with recurrent miscarriage. Prolongation in PT may be due to the presence of anti-prothrombin antibodies in serum of patients with recurrent miscarriage. The current study recommends measuring of APA, ACA, Anti-dsDNA-antibodies and assessment of platelets count, APTT and PT in all women with recurrent miscarriage and late pregnancy loss.
References
2. Asherson RA, Khamashta MA, Amengual O, Koike T. The primary antiphospholipid syndrome. Medicine 2006; 68: 584-589.
3. Ahmed A, Ortashi, O. M., Abdelmagied, A. H., Ramzi, M. S. Risk factors for recurrent miscarriage in Sudanese women. Saudi Medical journal 2004; 25:395-399.
4. Aznar J, Gilabert J, Estellesm A, Espana F. Fibrinolytic activity and protein C in preeclampsia. Thrombosis Haemostasis 2005; 55:314—7.
5. Cosgriff TM, Martin BA, Fishel LA. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Rheumatology journal 2009; 24: 94-96.
6. Kharnashta MA,Filip O, Smith G . Detection and importance of anticardiolipin antibodies. Journal ClinicalPathology 2009; 46:104-107.
7. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007;369 : 587–596.
8. Cordts PR, Gawley TS. Anatomic and physiologic changes in lower extremity venous hemodynamic associated with pregnancy. Rheumatology journal 2004; 24: 763-767.
9. Branch WD, Silver, RM, Blackwell, JL. Outcome of treated pregnancies in women with antiphospholipid syndrome. Obstetric Gynecology 2009; 80:614.
10. Rai R, Regan L, Hadley E, Dave M and Cohen H Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol.1996;92:489–490.
11. Pierangeli SS, Chen PP, Raschi E, et al. Antiphospholipid antibodies and the antiphospholipid 1. syndrome: pathogenic mechanisms. Semin Thromb Hemost. 2008;34:236-250.
12. Rand JH, Wu XX, Quinn AS, Taatjes DJ. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. Lupus. 2008;17:922-930.
13. Silver RK, Adler L, Hageman .JR, Hickman AR. Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production. American Journal Obstetrics Gynecolology 2009; 165:1748-1752.
14. Shibata, S., Harpel, P., Bona, C. and Fillit, H. (1993) Monoclonal antibodies to heparin sulfate inhibit the formation of thrombin–antithrombin III complexes. Clin. Immunol. Immunopathol., 67, 264–272.
15. Kovalevsky G, Gracia CR, Berlin JA, Sammel 7MD, Barnhart KT. Evaluation of the platelets count in 540 women recurrent miscarriage. Lancet 2004; 164:558–563.
16. Lin YL, Wang CT. thrombocytopenia in the antiphospholipid syndrome. Blood 2008; 80: 3135- 3143.
17. Elhasan T. Comparison of antiphospholipid antibodies and anticardiolipin antibodies in women with recurrent pregnancy loss. A thesis submitted for partial fulfillment of M.Sc. degree in Immunology 2007. Sudan academy of Science and Technology.
18. Sanson BJ, Lensing A W, Prins MH, Ginsberg JS, Barkagan ZS, LavennePardonge E. prevalence of nuclear auto-antibodies associated to miscarriage. Thrombosis Haemostasis 2009; 81:668 -672.
19. Rochat RW, Koonin LM, Atrash HK, Jewett JF. Determination of antinuclear antibodies and antidouble strand DNA in sera of Italian women with recurrent miscarriage.Obstetric Gynecology 2005; 72: 91-97.
20. Farnan J, Lavstida MT, Grant J A, Reddi C et al. antinuclear antibodies and anti-double strand DNA in the serum of Colombian women with recurrent miscarriage: a prospective study. Journal Clinical lmrnunology 2006 ; 73:596-599.
21. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thrombosis Haemostasis 2008; 52: 76-82.
22. Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphatidyl serine antibodies in women with recurrent abortion. Indian Journal of Medical Sciences 2005; 59:347–352.
23. Zolghadri, B. The prevalence of antiphospholipid syndrome in patients with recurrent pregnancy loss: A report from South of Iran. Medical Journal of the Islamic Republic of Iran. 2004; 18: 119-121.
24. Vaidyanathana Gr, Achanira M, M, Yahya A. Recurrent early pregnancy loss and consanguinity in Omani couples. Acta Obstetricia Gynecologica Scandinavica.2011;11:1167–1169.
25. Munther A, Khawashta E. case –control study in women with recurrent miscarriage form lupus unit. British Medical Journal 2004; 25:314.
26. Bretolacini ML,Atsumi T, Hunt BJ . Prothrombin mutation is not associated with thrombosis in patients with antiphospholipid syndrome. Thrombosis Haemostasis 2007; 80: 202.
27. Cauchi, MN., Coulam, C.B., Cowchock, S. The antiprothrombin antibodies in women with recurrent miscarrage. American Journal Reprod Immunology 2003; 33: 165-170.
